A carregar...
BI-33 BEVACIZUMAB-INDUCED HYPERTENSION IS A PREDICTIVE MARKER FOR IMPROVED OUTCOMES IN RECURRENT GLIOBLASTOMA
PURPOSE: Bevacizumab is a monoclonal antibody targeting vascular endothelial growth factor (VEGF) approved for treatment of recurrent glioblastoma (GBM). Previous studies have demonstrated differential outcomes for patients treated with this agent for other tumors based on whether hypertension devel...
Na minha lista:
| Main Authors: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4217902/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou239.33 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|